FDA Brief

FDA warning letters

A warning letter is FDA's formal notice that a company broke the law, usually found during an inspection. The company has 15 working days to reply. Letters that go unanswered lead to seizures, import bans or court orders.

234 letters match. Newest first.

  1. Natural Essentials, Inc.

    FDA warns Natural Essentials over OTC drug manufacturing violations, including inadequate failing test result investigations and missing component identity tests.

    High risk
  2. Shenzhen Benliju Biotech Co., Ltd.

    FDA: Shenzhen Benliju Biotech released OTC drugs labeled sterile without sterility testing or process validation.

    High risk
  3. CNC Noodle Corporation

    FDA warned CNC Noodle Corporation that its Hayward, California noodle plant had insanitary conditions, no pathogen or allergen controls, and mislabeled products.

    High risk
  4. Q’s American Best Trading Inc.

    FDA warned Q’s American Best Trading that it lacked required foreign supplier verification for imported cinnamon, corn, and instant noodles.

    High risk
  5. Nanjing Hanxin Pharmaceutical Technology Co. Ltd.

    FDA warns Nanjing Hanxin of drug-ingredient quality failures and poor supplier oversight; its drugs face U.S. import detention.

    High risk
  6. Chongqing Qiancan Technology Co., Ltd.

    Chongqing Qiancan Technology, an API maker in China, refused FDA records requests; FDA placed its drugs on import alert 66-79.

    High risk
  7. Tianjin Healthcare Medical Technology Co., Ltd.

    Chinese API maker refused FDA records requests, and all its drugs now face a US import alert.

    High risk
  8. Peakopia Produce

    FDA says Peakopia Produce lacked required Foreign Supplier Verification Program (FSVP) records for several imported fresh produce items.

    Medium
  9. Carive Imports Inc.

    Carive Imports failed to provide required records for imported garlic paste, cookies, noodles and pigeon peas after FDA requested them.

    High risk
  10. Karcz Nation, LLC

    Wisconsin dairy farm sold cows for slaughter with illegal antibiotic residues after off-label ceftiofur and ampicillin use, FDA says.

    High risk
  11. Mseafood Corporation

    Mseafood Corporation lacked required foreign supplier verification for imported cocktail sauce, FDA says.

    Medium
  12. RonanRx, Inc. dba RonanRx

    FDA says RonanRx's website and X posts misbrand compounded semaglutide and tirzepatide with false or misleading claims.

    Low
  13. Conroe Welding Supply, Inc.

    FDA warns Conroe Welding Supply over medical oxygen manufacturing failures, including untested batches and a container with 99% (b)(4).

    High risk
  14. Pritam International Private Limited

    Pritam International, an Indian OTC drug maker, was cited for CGMP violations, falsified lab data, unsafe color additive, and DEG/EG testing gaps.

    High risk
  15. Guangzhou Jiugong Research And Development Biotechnology Co., Ltd.

    Guangzhou Jiugong, an OTC drug maker, used a color additive FDA cancelled in 1976 and fell short of CGMP.

    High risk
  16. Guangdong Bisutang Biotechnology Co., Ltd.

    Guangdong Bisutang Biotechnology refused FDA records requests for OTC drugs and used a cancelled color additive in sunscreen.

    High risk
  17. Safi Pushcart Supplies Inc.

    FDA warns Safi Pushcart Supplies it imports basmati rice and blended soybean/olive oil with no foreign supplier verification program in place.

    Medium
  18. Sanrace Biotechnology Co., Ltd.

    FDA warns Sanrace Biotechnology over CGMP failures in OTC drugs, including missing identity tests and no process validation.

    High risk
  19. TSP Solutions Pte. Ltd.

    FDA warns Singapore OTC drug maker TSP Solutions over missing release testing and component identity checks for sunscreens.

    High risk
  20. Pro-Optics, LLC

    FDA warned Pro-Optics about unapproved material and color changes to contact lens cases and quality system failures.

    Medium
  21. Peter Schiff Enterprises

    FDA warns Peter Schiff Enterprises over unapproved cardiac devices and serious quality system failures.

    High risk
  22. Rohto Pharmaceutical Co., Ltd.

    FDA cites Rohto Vietnam eye-drop plant for falsified sterility records, poor aseptic practices, and unapproved Cooling Eye Drops.

    High risk
  23. Tides Medical LLC

    FDA warns Tides Medical over APLICOR 3D wound device sold without approval, exemption, or required FDA notice.

    High risk
  24. Zhejiang Gaorong Cosmetic Co., Ltd.

    FDA cited Zhejiang Gaorong Cosmetic for OTC drug CGMP violations in component testing and quality unit oversight.

    High risk
  25. SnugZ USA, Inc.

    SnugZ USA, an OTC drug maker in West Jordan, Utah, was cited for releasing drugs after retesting failed batches until they passed.

    High risk
  26. Eurofins SF Analytical Laboratories, Inc.

    FDA warned Eurofins SF Analytical Laboratories, a contract drug-testing lab, that it kept incomplete microbial test records and skipped required investigations.

    High risk
  27. Silgan Dispensing Systems

    Silgan Unicep Packaging was cited for manufacturing quality failures and unapproved new drugs after invalidated microbial tests and a fungal recall.

    High risk
  28. Hanlim Pharm Co., Ltd.

    FDA warned Hanlim Pharm over serious sterile manufacturing violations, including poor aseptic practices and airflow problems, at its South Korea plant.

    High risk
  29. John & Nicole Santos Dairy

    John & Nicole Santos Dairy of Hilmar, California sold dairy cows for slaughter containing ampicillin residues above the legal limit.

    High risk
  30. Dreyer’s Grand Ice Cream, Inc.

    FDA warns Dreyer’s Grand Ice Cream over Listeria and sanitation failures in frozen RTE ice cream.

    High risk
  31. Jiangmen Shuizirun Sanitary Articles Co., Ltd.

    FDA warns Chinese OTC drug maker Jiangmen Shuizirun for labeling products sterile without sterilizing them or testing for sterility.

    High risk
  32. Datil Fresh Produce LLC

    Datil Fresh Produce LLC lacked foreign supplier verification for imported scallions, cabbage, and cucumber, FDA found.

    Medium
  33. RDM Express Inc.

    FDA says RDM Express made ready-to-eat fermented cabbage under insanitary conditions and without adequate pathogen controls.

    High risk
  34. Ocean Pride Seafood, Inc.

    FDA warned Ocean Pride Seafood that its ready-to-eat seafood was adulterated (unsafe under law) due to missing seafood safety (HACCP) controls and insanitary conditions.

    High risk
  35. Moda Food LLC

    Moda Food LLC lacked FSVP records for imported Phyllo, Baklava and Tahini Halva, FDA found.

    Medium
  36. Distribuidora Jazmin LLC

    FDA warns Distribuidora Jazmin LLC over missing foreign supplier verification for imported corn chips.

    Medium
  37. Ruukoo International Food Market Inc.

    FDA warns Bronx importer Ruukoo International Food Market for lacking an FSVP for imported fresh yams and other foods.

    Medium
  38. TCI Co., Ltd BioCosme PABP BRANCH

    FDA warns Taiwan OTC drug contract manufacturer TCI BioCosme over CGMP violations, including incomplete release and ingredient testing.

    High risk
  39. Star Ocean Wholesale Foods, Inc.

    FDA warns Star Ocean Wholesale Foods over missing checks for imported fermented fish sauce.

    High risk
  40. Importaciones La Bufa LLC

    FDA warns Texas food importer Importaciones La Bufa for lacking foreign supplier verification program (FSVP) for imported foods.

    Medium
  41. Pine Pharmaceuticals, LLC

    FDA cited outsourcing facility Pine Pharmaceuticals in Tonawanda, NY, for insanitary sterile compounding conditions and CGMP failures after a November 2025 inspection.

    High risk
  42. Babikian Healthcare Products CJSC

    FDA warns Babikian Healthcare Products over manufacturing quality failures for over-the-counter drugs, including missing identity and finished-product testing.

    High risk
  43. Curia New York, Inc.

    FDA warned Curia New York's Rensselaer, New York API plant that undocumented lab injections, shredded records and shared passwords violate CGMP.

    High risk
  44. Andrighetto Produce Inc dba Shasta Produce Inc

    FDA found Andrighetto Produce lacked a Foreign Supplier Verification Program for most imported fresh produce and hazard-analysis review.

    High risk
  45. Bo Wah Enterprises Inc

    Bo Wah Enterprises lacked required supplier checks for imported yam, mushroom, and sesame paste.

    Medium
  46. American Pharma Mfg. Inc.

    FDA warns American Pharma Mfg. of serious dietary supplement manufacturing violations at its Ontario, CA facility.

    High risk
  47. Wilson Livestock

    Wilson Livestock sold a heifer with excess desfuroylceftiofur residue and used a cephalosporin drug outside approved labeling for disease prevention.

    High risk
  48. Fil-Bay Import, Inc.

    Fil-Bay Import lacked required foreign supplier safety plans for many imported foods and canned-food processing checks.

    High risk
  49. Middlefield Original Cheese Cooperative

    FDA warns Middlefield Original Cheese Cooperative about Listeria and insanitary conditions in its ready-to-eat cheese.

    High risk
  50. Empower Clinic Services, LLC dba Empower Pharmacy

    FDA warned Empower Pharmacy over unapproved compounded semaglutide/tirzepatide copies and sterile manufacturing deficiencies that put patients at risk.

    High risk